`
`ass,
`
`News
`Select
`
`vl
`
`Mylan to Present at Goldman Sachs 36th
`Annual Global Healthcare Conference
`
`
`HERTFORDSHIRE, England AND PITTSBURGH, June 3, 2015 /PRNewswire/ -- Mylan N.V. (Nasdaq:
`MYL), a leading global pharmaceutical company, today announced that the Company will present at
`Goldman Sachs 36'h Annual Global Healthcare Conference on Tuesday June 9, 2015. The
`presentation is scheduled to begin at 4 p.m. PT / 7 p.m. ET.
`
`Interested parties can access a live webcast of the presentation via the investor relations section of
`Mylan's website at http: / /mylan.com /investors.
`
`Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working
`together around the world to provide 7 billion people access to high quality medicine, we innovate to
`satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy;
`and impact the future through passionate global leadership. We offer a growing portfolio of around
`1,400 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of
`antiretroviral therapies, upon which approximately 40% of HIV /AIDS patients in developing countries
`depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and
`currently market products in about 145 countries and territories. Our workforce of approximately 30,000
`people is dedicated to creating better health for a better world, one person at a time. Learn more at
`mylan.com
`
`SOURCE Mylan N.V.
`
`For further information: Nina Devlin (Media), 724.514.1968, Kris King (Investors), 724.514.1813
`
`NCI Exhibit 2044